MedTrace Logo

Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone

NCT00323843 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2007-01-30

No results posted yet for this study

Summary

Is it possible to decrease the intrarenal pressure in the kidney during endoscopic management of kidney stone by topical administration of drugs? In order to secure fewer complications in ureteroscopic operations the pharmacological agent isoproterenol is tested on pigs and human to determine its potential of lowering intrarenal pressure.

Conditions

  • Kidney Stone
  • Ureteroscopy

Interventions

DRUG

Isoproterenol

Sponsors & Collaborators

  • Fredericia Hosptial

    lead OTHER

Principal Investigators

  • Helene U Jung · Fredericia Hospital, Dpt. of Urology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Completion
2007-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00323843 on ClinicalTrials.gov